StockData
Merck & Co., Inc. logo

Merck & Co., Inc. (MRK) operating KPIs

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)

Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%

Merck accounts Receivable, Net ($M) ($M)

Postgres DB financial_values

QuarterlyAnnual
Latest, FY2025
11,775
Period ended Dec 31, 2025
Change on a year earlier
+14.6%
10,278 in FY2024
History
18 years
Since FY2008
Sources
17
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAccounts Receivable, Net ($M) ($M)Year on yearSource
FY2025Dec 31, 202511,775+14.6%Form 10-K (filed 2026-02-24) ↗
FY2024Dec 31, 202410,278-0.7%Form 10-K (filed 2025-02-25) ↗
FY2023Dec 31, 202310,349+9.5%Form 10-K (filed 2024-02-26) ↗
FY2022Dec 31, 20229,450+2.4%Form 10-K (filed 2023-02-24) ↗
FY2021Dec 31, 20219,230+35.7%Form 10-K (filed 2022-02-25) ↗
FY2020Dec 31, 20206,803+0.4%Form 10-Q (filed 2021-08-09) ↗
FY2019Dec 31, 20196,778-4.1%Form 10-K (filed 2020-02-26) ↗
FY2018Dec 31, 20187,071+2.9%Form 10-K (filed 2019-02-27) ↗
FY2017Dec 31, 20176,873-2.1%Form 10-K (filed 2018-02-27) ↗
FY2016Dec 31, 20167,018+8.2%SEC Filing ↗
FY2015Dec 31, 20156,484-2.1%Form 10-K (filed 2016-02-26) ↗
FY2014Dec 31, 20146,626-7.8%Form 10-K (filed 2015-02-27) ↗
FY2013Dec 31, 20137,184-6.4%Form 10-K (filed 2014-02-27) ↗
FY2012Dec 31, 20127,672-7.1%Form 10-K (filed 2013-02-28) ↗
FY2011Dec 31, 20118,261+12.5%Form 10-K (filed 2012-02-28) ↗
FY2010Dec 31, 20107,344+11.2%Form 10-K (filed 2011-02-28) ↗

Breakdown

What makes up accounts receivable, net ($m)

Cite this data

StockData. (2026). Merck Accounts Receivable, Net ($M) ($M), annual FY2008–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/db_bal_ar

See every metric in the Merck KPI table. Data updated Oct 26, 2026.